RECRUITING
NCT07543003
An International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)
Updated: May 11, 2026
- RECRUITINGNCT07521930
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Updated: Apr 13, 2026 - RECRUITINGNCT07488338
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Updated: Mar 23, 2026 - RECRUITINGNCT07478172
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Updated: Mar 17, 2026 - RECRUITINGNCT07467187
Invasive Home Ventilation in Denmark
Updated: Apr 20, 2026 - RECRUITINGNCT07444476
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
Updated: Apr 21, 2026 - RECRUITINGNCT07400198
Gait and Bone Health in SMA
Updated: Mar 18, 2026 - RECRUITINGNCT07336446
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
Updated: May 1, 2026 - RECRUITINGNCT07332702
Long Read Analysis in Spinal Muscular Atrophy - LOREASI
Updated: Jan 12, 2026 - RECRUITINGNCT07321977
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Updated: Jan 7, 2026 - RECRUITINGNCT07287982
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Updated: Apr 22, 2026 - RECRUITINGNCT07286565
Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening
Updated: Dec 16, 2025 - RECRUITINGNCT07265232
Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).
Updated: Dec 4, 2025 - RECRUITINGNCT07231549
CuidAME: Longitudinal Data Collection From Patients With Spinal Muscular Atrophy in Spain
Updated: Nov 17, 2025 - RECRUITINGNCT07223489
Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
Updated: Jan 16, 2026 - RECRUITINGNCT07221669
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Updated: May 6, 2026 - RECRUITINGNCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Updated: May 11, 2026 - RECRUITINGNCT07070999
Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1
Updated: Mar 2, 2026 - RECRUITINGNCT06978985
Adult SMA Research and Clinical Hub
Updated: May 18, 2025 - RECRUITINGNCT06977269
Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy
Updated: Jun 18, 2025
Filter Search
Country*
Sex
Age Group
Observational & Interventional Studies
Expanded Access
Preferred Study Type
Evaluates effect of interventions, e.g. substances
e.g. Patient Registries
Save my filters & notify me of new trials!
Never miss a new SMA Clinical Trial
Register to receive email notifications of new trials matching your profile or updates to saved trials